InsidersTradesSigma
ADC Therapeutics SA Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the ADC Therapeutics SA stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €162.8m. The latest transaction was filed on 2 July 2026 (Attribution). Among the most active insiders: Redmile Group, LLC. Every trade is openly available.
73
Insider Decl.
n/a
Thresholds
€1m
2 ops.
Buy Volume
€17m
15 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ADC Therapeutics SA Buy (bullish), based on 3 analysts. Average price target: US$5.00.
36Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations73 total
675,000 sharesCommon SharesSEC:0001628280-26-047031:0
203,700 sharesCommon SharesSEC:0001628280-26-047033:0
221,100 sharesCommon SharesSEC:0001628280-26-047034:0
213,900 sharesCommon SharesSEC:0001628280-26-047036:0
45,000 shares0Common SharesSEC:0001628280-26-040487:0
12,600 shares@ US$3.08100.0% of flowCommon SharesSEC:0001628280-26-040487:1
45,000 shares0Common SharesSEC:0001628280-26-040488:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040488:1
45,000 shares0Common SharesSEC:0001628280-26-040490:0
2,596 shares@ US$3.0836.8% of flowCommon SharesSEC:0001628280-26-040490:1
45,000 shares0Common SharesSEC:0001628280-26-040491:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040491:1
45,000 shares0Common SharesSEC:0001628280-26-040492:0
15,196 shares@ US$3.0838.0% of flowCommon SharesSEC:0001628280-26-040492:1
45,000 shares0Common SharesSEC:0001628280-26-040493:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040493:1
196,229 shares@ US$3.7523.5% of flowCommon StockSEC:0001104659-26-039359:0
188,407 shares@ US$3.7523.4% of flowCommon StockSEC:0001104659-26-039359:1
169,265 shares@ US$3.7993.0% of flowCommon StockSEC:0001104659-26-039359:2
162,517 shares@ US$3.7992.9% of flowCommon StockSEC:0001104659-26-039359:3
2,634,506 shares@ US$3.27941.1% of flowCommon StockSEC:0001104659-26-039359:4
2,529,491 shares@ US$3.27939.5% of flowCommon StockSEC:0001104659-26-039359:5
53,236 shares@ US$3.2922.6% of flowCommon SharesSEC:0001628280-25-056168:0
25 of 73 declarations
About ADC Therapeutics SA
ADC Therapeutics SA is a biopharmaceutical company focused on developing targeted therapies for cancer treatment. It specializes in antibody-drug conjugates and innovative treatments to improve patient outcomes.